Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Impaired Cerebrovascular Reactivity in Multiple Sclerosis.
Simvastatin in patients with progressive multiple sclerosis--Authors' reply.
Multiple sclerosis: Infertility treatment increases multiple sclerosis activity.
Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study.
Visualizing iron in multiple sclerosis.
Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.
Neuromyelitis optica and pregnancy.
The most fulminant course of the Marburg variant of multiple sclerosis-autopsy findings.
Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study.
Differential roles of resident microglia and infiltrating monocytes in murine CNS autoimmunity.
Does hippotherapy effect use of sensory information for balance in people with multiple sclerosis?
The Effect of Fingolimod on Conversion of Acute Gadolinium-Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis.
Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
To be 17 again--anti-interleukin-17 treatment for psoriasis.
Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.
Multiple Sclerosis: Current Knowledge and Future Outlook.
Proteasome Inhibitors: A New Perspective for Treating Autoimmune Diseases.
Simultaneous Pml-Iris After Discontinuation of Natalizumab in A Patient With MS.
Using magnetic resonance imaging as a means to study chronic cerebral spinal venous insufficiency in multiple sclerosis patients.
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine.
Neuroprotection and repair in multiple sclerosis.
Better look (and think) twice-TNF-alpha-inhibition and multiple sclerosis.
The association of -475 and -631 interleukin-2 gene polymorphism with multiple sclerosis in Iranian patients.
Longitudinally Extensive Transverse Myelitis With and Without Aquaporin 4 Antibodies.
Alpha-B-crystallin induces an immune-regulatory and antiviral microglial response in preactive multiple sclerosis lesions.
Pages
« first
‹ previous
…
378
379
380
381
382
383
384
385
386
…
next ›
last »